Dual neutralization of IL-17A and IL-17F with bimekizumab improves quality of life in patients withmoderate-to-severe plaque psoriasis: results from a Phase 2b study and correlation with clinical response

Main Article Content

Kim A Papp
Joseph F Merola
Alice B Gottlieb
Et al.



Abstract not available.


Disclosures: Study sponsored by UCB Pharma.

Copyright 2018 SKIN

Most read articles by the same author(s)

1 2 3 4 > >>